95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Xinhua Chen1†
Huimin Zhang2†
Minghao Wang1†
Hao Liu1
Yanfeng Hu1
Tian Lin1Hao Chen1Mingli Zhao1
Tao Chen1
Guoxin Li1*
Jiang Yu1*
Liying Zhao1*- 1Department of General Surgery and Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou, China
- 2The First Clinical Medical School, Southern Medical University, Guangzhou, China
A Corrigendum on
Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients
By Chen X, Zhang H, Wang M, Liu H, Hu Y, Lin T, Chen H, Zhao M, Chen T, Li G, Yu J and Zhao L (2022) Front. Immunol. 13:783695. doi: 10.3389/fimmu.2022.783695
In the published article, there was an error in the author list, and author Guoxin Li was listed erroneously, and should be denoted as a corresponding author. The corrected author list appears below.
Xinhua Chen1†, Huimin Zhang2†, Minghao Wang1†, Hao Liu1, Yanfeng Hu1, Tian Lin1, Hao Chen1, Mingli Zhao1, Tao Chen1, Guoxin Li1*, Jiang Yu1*, Liying Zhao1*
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: gastric cancer, PD-L1, CPS, Ki-67, biopsy, pathology
Citation: Chen X, Zhang H, Wang M, Liu H, Hu Y, Lin T, Chen H, Zhao M, Chen T, Li G, Yu J and Zhao L (2023) Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients. Front. Immunol. 14:1235273. doi: 10.3389/fimmu.2023.1235273
Received: 06 June 2023; Accepted: 07 June 2023;
Published: 15 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Chen, Zhang, Wang, Liu, Hu, Lin, Chen, Zhao, Chen, Li, Yu and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Liying Zhao, emx5Ymx1ZTExQDE2My5jb20=; Jiang Yu, YmFsYmNAMTYzLmNvbQ==; YmFsYmN5dWppYW5nQDE2My5jb20=; Guoxin Li, Z3psaWd1b3hpbkAxNjMuY29t
†These authors have contributed equally to this work